Hiroshi Eizawa
Impact in
- Biochemistry top 5%
- Eicosanoids and Hypertension Pharmacology
- Physiology top 5%
- Nitric Oxide and Endothelin Effects
Papers in
-
- Nitric Oxide and Endothelin Effects 9
-
- Atrial Fibrillation Management and Outcomes 2
- Renin-Angiotensin System Studies 2
- Chemotherapy-induced cardiotoxicity and mitigation 2
- Co-authors
- Yoshiki Yui (11 shared papers)Ryuichi Hattori (11 shared papers)Kazuaki Hiki (5 shared papers)K Kosuga (3 shared papers)C Kawai (3 shared papers)Kunihiko Kosuga (8 shared papers)Chuichi Kawai (6 shared papers)Shigetake Sasayama (5 shared papers)
- Journals
- International Journal of Cardiology (2 papers)Journal of Biological Chemistry (2 papers)Circulation (1 paper)Endothelium (1 paper)The Japanese Journal of Pharmacology (2 papers)
- Partner nations
- Japan
In The Last Decade
Hiroshi Eizawa
12 papers receiving 586 citations
Peers
Comparison fields: 5 of 79
- Biochemistry 166
- Physiology 425
- Toxicology 38
- Biophysics 44
- Endocrine and Autonomic Systems 45
Countries citing papers authored by Hiroshi Eizawa
This map shows the geographic impact of Hiroshi Eizawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Eizawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Eizawa more than expected).
Fields of papers citing papers by Hiroshi Eizawa
This network shows the impact of papers produced by Hiroshi Eizawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Eizawa. The network helps show where Hiroshi Eizawa may publish in the future.
Co-authors
The 25 scholars most cited alongside Hiroshi Eizawa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1991 | 206 | |
| 2 | 1991 | 167 | |
| 3 | 1994 | 52 | |
| 4 | 1995 | 49 | |
| 5 | 1994 | 37 | |
| 6 | 1991 | 36 | |
| 7 | 1991 | 24 | |
| 8 | 1994 | 12 | |
| 9 | 1993 | 11 | |
| 10 | 1991 | 5 | |
| 11 | 1995 | 1 | |
| 12 | [Multiple cavities in myocardium of left ventricle after irradiation therapy for breast cancer: a case report]. | 1999 | 1 |
| 13 | 2025 | 0 | |
| 14 | 2025 | 0 | |
| 15 | 2024 | 0 |
About Hiroshi Eizawa
Hiroshi Eizawa is a scholar working on Physiology, Cardiology and Cardiovascular Medicine, Surgery, Molecular Biology and Biochemistry, having authored 15 papers that have together received 601 indexed citations. Recurring topics across this work include Nitric Oxide and Endothelin Effects (9 papers), Eicosanoids and Hypertension Pharmacology (3 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers), Atrial Fibrillation Management and Outcomes (2 papers), Renin-Angiotensin System Studies (2 papers), Cardiac Structural Anomalies and Repair (2 papers), Electron Spin Resonance Studies (2 papers) and Chemotherapy-induced cardiotoxicity and mitigation (2 papers). The work is most often cited by research in Biochemistry (166 citations), Physiology (425 citations), Toxicology (38 citations), Biophysics (44 citations) and Endocrine and Autonomic Systems (45 citations). Hiroshi Eizawa has collaborated with scholars based in Japan. Frequent co-authors include Yoshiki Yui, Ryuichi Hattori, Kazuaki Hiki, K Kosuga, C Kawai, Kunihiko Kosuga, Chuichi Kawai, Shigetake Sasayama, Takeshi Aoyama and Daisuke Inoue. Their work appears in journals such as International Journal of Cardiology, Journal of Biological Chemistry, Circulation, Endothelium and The Japanese Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.